These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32527589)

  • 1. Characterizing cognitive-motor impairments in patients with myotonic dystrophy type 1.
    Filli L; Schwegler S; Meyer C; Killeen T; Easthope CS; Broicher SD; Curt A; Zörner B; Bolliger M; Jung HH; Petersen JA
    Neuromuscul Disord; 2020 Jun; 30(6):510-520. PubMed ID: 32527589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of temporal and stride characteristics in myotonic dystrophies type 1 and 2 during dual-task walking.
    Radovanović S; Perić S; Savić-Pavićević D; Dobričić V; Pešović J; Kostić V; Rakočević-Stojanović V
    Gait Posture; 2016 Feb; 44():194-9. PubMed ID: 27004657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of cognitive impairments in myotonic dystrophy type 1 explained by three distinct cognitive profiles.
    Davion JB; Tard C; Fragoso L; Wilu-Wilu A; Skrobala E; Defebvre L; Delbeuck X
    J Neurol; 2024 Jul; 271(7):4529-4539. PubMed ID: 38709306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-Task Effects During a Motor-Cognitive Task in Parkinson's Disease: Patterns of Prioritization and the Influence of Cognitive Status.
    Johansson H; Ekman U; Rennie L; Peterson DS; Leavy B; Franzén E
    Neurorehabil Neural Repair; 2021 Apr; 35(4):356-366. PubMed ID: 33719728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvements in temporal and postural aspects of gait vary following single- and multi-modal training in individuals with Parkinson's disease.
    Rosenfeldt AB; Penko AL; Streicher MC; Zimmerman NM; Koop MM; Alberts JL
    Parkinsonism Relat Disord; 2019 Jul; 64():280-285. PubMed ID: 31103489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paving the way for a better understanding of the pathophysiology of gait impairment in myotonic dystrophy: a pilot study focusing on muscle networks.
    Naro A; Portaro S; Milardi D; Billeri L; Leo A; Militi D; Bramanti P; Calabrò RS
    J Neuroeng Rehabil; 2019 Sep; 16(1):116. PubMed ID: 31533780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between muscle impairments, postural stability, and gait parameters assessed with lower-trunk accelerometry in myotonic dystrophy type 1.
    Bachasson D; Moraux A; Ollivier G; Decostre V; Ledoux I; Gidaro T; Servais L; Behin A; Stojkovic T; Hébert LJ; Puymirat J; Eymard B; Bassez G; Hogrel JY
    Neuromuscul Disord; 2016 Jul; 26(7):428-35. PubMed ID: 27234310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatiotemporal gait characteristics of Huntington's disease during dual-task walking.
    Radovanović S; Vodopić S; Stanković I; Dragašević-Mišković N; Kostić V
    Int J Neurosci; 2020 Feb; 130(2):136-143. PubMed ID: 31516046
    [No Abstract]   [Full Text] [Related]  

  • 9. Major involvement of trunk muscles in myotonic dystrophy type 1.
    Solbakken G; Ørstavik K; Hagen T; Dietrichs E; Naerland T
    Acta Neurol Scand; 2016 Dec; 134(6):467-473. PubMed ID: 26984572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gait abnormalities in minimally disabled people with Multiple Sclerosis: A 3D-motion analysis study.
    Liparoti M; Della Corte M; Rucco R; Sorrentino P; Sparaco M; Capuano R; Minino R; Lavorgna L; Agosti V; Sorrentino G; Bonavita S
    Mult Scler Relat Disord; 2019 Apr; 29():100-107. PubMed ID: 30703704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual tasking in Parkinson's disease: Cognitive consequences while walking.
    Salazar RD; Ren X; Ellis TD; Toraif N; Barthelemy OJ; Neargarder S; Cronin-Golomb A
    Neuropsychology; 2017 Sep; 31(6):613-623. PubMed ID: 28414497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minor gait impairment despite white matter damage in pure small vessel disease.
    Finsterwalder S; Wuehr M; Gesierich B; Dietze A; Konieczny MJ; Schmidt R; Schniepp R; Duering M
    Ann Clin Transl Neurol; 2019 Oct; 6(10):2026-2036. PubMed ID: 31524338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive decline over time in adults with myotonic dystrophy type 1: A 9-year longitudinal study.
    Gallais B; Gagnon C; Mathieu J; Richer L
    Neuromuscul Disord; 2017 Jan; 27(1):61-72. PubMed ID: 27919548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of explicit prioritization on dual task walking in patients with Parkinson's disease.
    Yogev-Seligmann G; Rotem-Galili Y; Dickstein R; Giladi N; Hausdorff JM
    Gait Posture; 2012 Apr; 35(4):641-6. PubMed ID: 22342204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive phenotype of childhood myotonic dystrophy type 1: A multicenter pooled analysis.
    Sweere DJJ; Moelands SVL; Klinkenberg S; Leenen L; Hendriksen JGM; Braakman HMH
    Muscle Nerve; 2023 Jul; 68(1):57-64. PubMed ID: 37129457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional impairment in patients with myotonic dystrophy type 1 can be assessed by an ataxia rating scale (SARA).
    DiPaolo G; Jimenez-Moreno C; Nikolenko N; Atalaia A; Monckton DG; Guglieri M; Lochmüller H
    J Neurol; 2017 Apr; 264(4):701-708. PubMed ID: 28168524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motor cortex and gait in mild cognitive impairment: a magnetic resonance spectroscopy and volumetric imaging study.
    Annweiler C; Beauchet O; Bartha R; Wells JL; Borrie MJ; Hachinski V; Montero-Odasso M
    Brain; 2013 Mar; 136(Pt 3):859-71. PubMed ID: 23436505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease awareness in myotonic dystrophy type 1: an observational cross-sectional study.
    Baldanzi S; Bevilacqua F; Lorio R; Volpi L; Simoncini C; Petrucci A; Cosottini M; Massimetti G; Tognoni G; Ricci G; Angelini C; Siciliano G
    Orphanet J Rare Dis; 2016 Apr; 11():34. PubMed ID: 27044540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified dynamic gait index and limits of stability in myotonic dystrophy type 1.
    Pucillo EM; Mcintyre MM; Pautler M; Hung M; Bounsanga J; Voss MW; Hayes H; Dibella DL; Trujillo C; Dixon M; Butterfield RJ; Johnson NE
    Muscle Nerve; 2018 Nov; 58(5):694-699. PubMed ID: 30160307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frontostriatal dysexecutive syndrome: a core cognitive feature of myotonic dystrophy type 2.
    Peric S; Mandic-Stojmenovic G; Stefanova E; Savic-Pavicevic D; Pesovic J; Ilic V; Dobricic V; Basta I; Lavrnic D; Rakocevic-Stojanovic V
    J Neurol; 2015 Jan; 262(1):142-8. PubMed ID: 25346064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.